May 13, 2009 / 6:35 AM / in 10 years

MediBic Group <2369.T>-1qtr group results

   May 13 (Reuters) -
                MEDIBIC GROUP
                CONSOLIDATED FINANCIAL HIGHLIGHTS
 (in billions of yen unless specified)
             3 months ended  3 months ended    6 months to     Year to   
               Mar 31, 2009    Mar 31, 2008    Jun 30, 2009    Dec 31, 2009
               LATEST          YEAR-AGO        H1              LATEST    
               RESULTS         RESULTS         FORECAST        FORECAST  
 Sales                122 mln          87 mln         182 mln         549 mln
                                (-67.6 pct)                              
 Operating       loss 106 mln    loss 110 mln    loss 183 mln    loss 285 mln
 Recurring       loss 105 mln    loss 126 mln    loss 183 mln    loss 285 mln
 Net              loss 94 mln    loss 126 mln    loss 172 mln    loss 275 mln
 EPS             loss Y538.27    loss Y718.67    loss Y975.93  loss Y1,560.35
 NOTE - MediBic Group is a consulting firm, providing information on genome-based drugs.
 For latest earnings estimates made by Toyo Keizai, please
double click on 2369.TK1.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below